Skip to content
Home/Companies/MedTech/Positrigo

Positrigo

MedTech·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Positrigo?

Positrigo is a Swiss MedTech company, currently owned by HealthCap since 2025.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VIII · 2021 · VC

Key facts

HQSwitzerland
SectorMedTech
StatusActive

More from HealthCap VIII

Other portfolio companies in the same fund.

CurifyLabs
Active
MedTechFinland· 2026
Neobiomics
Active
BiotechSweden· 2026
Gesynta Pharma
Gesynta Pharma
Active
PharmaSweden· 2025
Kivu Bioscience
Active
BiotechUS· 2025
Rampart Biosciences
Active
BiotechUS· 2023
Ariceum Therapeutics
Active
BiotechGermany· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Positrigo?

Positrigo is currently owned by HealthCap, through HealthCap VIII, since 2025.

When did HealthCap acquire Positrigo?

HealthCap acquired Positrigo in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue